Ketamine Queen Pleads Guilty in Matthew Perry Death
Analysis based on 39 articles · First reported Aug 18, 2025 · Last updated Aug 19, 2025
This event has a limited direct market impact, primarily affecting the pharmaceutical industry's regulatory scrutiny on ketamine distribution. The legal proceedings against Jasveen Sangha and others highlight the risks associated with illicit drug markets.
Jasveen Sangha, known as the 'Ketamine Queen', has agreed to plead guilty to five federal criminal charges, including supplying the ketamine that caused the death of actor Matthew Perry in October 2023. She is the fifth and final defendant to reach a plea agreement with federal prosecutors, avoiding a trial. The investigation revealed that Matthew Perry's assistant, Kenneth Iwamasa, obtained ketamine from Dr. Salvador Plasencia and later from Jasveen Sangha through Erik Fleming. Jasveen Sangha maintained a stash house in North Hollywood, California, for distributing controlled substances. She faces up to 45 years in prison. Other defendants, including Salvador Plasencia, Erik Fleming, Kenneth Iwamasa, and Dr. Adema, have also pleaded guilty to various charges related to the distribution of ketamine to Matthew Perry.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard